WHO recognizes Bangladeshi vaccine for trial
Staff Correspondent || shiningbd
The World Health Organization (WHO) has approved the three coronavirus vaccines made by Bangladeshi pharmaceutical company Globe Biotech.
As seen today (Saturday) on the WHO website, the vaccines discovered by the Globe Biotech have been enlisted.
According to the WHO website, for pre-clinical trial, the World Health Organization has listed three vaccines of Globe Biotech Limited, a subsidiary of Globe Pharmaceuticals Group of Companies Limited.
Globe Biotech has also confirmed this information in a press release.
The World Health Organization (WHO) on October 15 added three vaccines discovered by Globe Biotech to its list of Covid-19 vaccine candidates.
The vaccines are D614G variant mFNA Vaccine, DNA Plasmid Vaccine, Adonocirus Typo-5 Vcctor Vaccine.
In an interview with the media on August 12, Globe Biotech Research and Development Department Head Dr. Asif Mahmud expressed hope that the coronavirus vaccine would be introduced in the Bangladeshi market in December. A month after expressing her optimism, the World Health Organization listed them for pre-clinical tests.
The list of pre-clinical trials includes 157 companies, including vaccines from the University of Cambridge.